It is thus possible that the improved tumor rejection in TSAd deficient Id-specific TCR transgenic T cells19 is caused by diffuse instead of polarized secretion of IFNγ during CD4+ T cell interactions with APC. The gene discussed is CD4; the disease is neoplasm.